In short
This article examines the use of Follitropin Alfa (Genetical Recombination), also known as recombinant follicle-stimulating hormone (rFSH), in clinical trials for fertility treatments. Follitropin Alfa is being studied in various contexts, including polycystic ovary syndrome (PCOS), ovarian stimulation for oocyte donation, and in women with predicted suboptimal response to ovarian stimulation. These trials aim to evaluate the effectiveness of different dosing regimens and compare Follitropin Alfa to other fertility medications.
At a glance
- Conditions Studied
- Polycystic Ovary Syndrome (PCOS), Ovarian Stimulation for Oocyte Donation, Predicted Suboptimal Responders
- Main Objectives
- Compare effectiveness of Follitropin Alfa to other medications, evaluate different dosing regimens, assess pregnancy rates, examine egg/embryo quality and quantity
- Dosage Forms
- Solution for injection (300 IU/0.5 mL, 450 IU/0.75 mL, 900 IU/1.5 mL)
- Administration Route
- Subcutaneous injection
- Key Inclusion Criteria
- Age 18-40, specific AMH and AFC levels, BMI 18.5-30 kg/m², infertility diagnosis
- Primary Endpoints
- Number of mature oocytes, pregnancy rates, number of good-quality blastocysts
- Secondary Endpoints
- Embryo development timelines, blastocyst formation rates, cycle cancellation rates, cost-effectiveness
What is Follitropin Alfa?
Follitropin alfa, also known by its brand name Ovaleap, is a recombinant human follicle-stimulating hormone (FSH) used in reproductive medicine. It is a genetically engineered version of the natural hormone FSH, which plays a crucial role in the development of eggs in women and sperm in men.
Medical Uses
Follitropin alfa is primarily used in the treatment of infertility. It is prescribed for:
- Women undergoing ovarian stimulation for assisted reproductive technologies (ART) such as in vitro fertilization (IVF)
- Women with anovulation (lack of ovulation)
- Women with polycystic ovary syndrome (PCOS)
- Stimulation of spermatogenesis in men with certain types of infertility
How It Works
Follitropin alfa works by mimicking the action of natural FSH in the body. In women, it stimulates the ovaries to produce and mature eggs. In men with certain types of infertility, it can stimulate sperm production. The hormone acts on the follicle-stimulating hormone receptors in the ovaries or testes, promoting the growth and development of reproductive cells.
Administration
Follitropin alfa is typically administered as a subcutaneous injection. This means it is injected just under the skin, usually in the abdomen or thigh. The medication comes in pre-filled pens or vials, making it easier for patients to self-administer at home after proper training from a healthcare professional.
Dosage
The dosage of follitropin alfa varies depending on the individual patient and their specific condition. Based on the clinical trial information, some common dosage ranges include:
- 50-75 IU daily for ovarian stimulation in women
- Up to 150-300 IU daily in certain protocols
It's important to note that the dosage is highly individualized and should be determined by a healthcare professional based on factors such as age, body weight, and response to treatment.
Current Clinical Trials
Several ongoing clinical trials are investigating the use of follitropin alfa in various contexts:
- A study comparing its efficacy to letrozole in women with polycystic ovary syndrome undergoing artificial insemination
- Research on its use in oocyte donation programs
- A trial examining different doses of follitropin alfa in combination with clomiphene citrate for women with predicted suboptimal ovarian response
These studies aim to optimize treatment protocols and expand our understanding of follitropin alfa's effectiveness in various fertility treatments.
Potential Side Effects
While follitropin alfa is generally well-tolerated, some potential side effects may include:
- Injection site reactions (redness, pain, or swelling)
- Headache
- Abdominal pain or bloating
- Nausea
- Ovarian hyperstimulation syndrome (OHSS) in rare cases
It's important to discuss any side effects with your healthcare provider.
Important Considerations
When using follitropin alfa, keep in mind:
- Regular monitoring through ultrasounds and blood tests is typically required during treatment to assess response and adjust dosage if necessary.
- The medication should be used under the supervision of a fertility specialist or endocrinologist.
- Follitropin alfa is part of a comprehensive fertility treatment plan and may be used in combination with other medications.
- Success rates vary depending on individual factors and the specific fertility issue being addressed.
Always consult with your healthcare provider for personalized information and guidance regarding the use of follitropin alfa in your fertility treatment.